Currently Enrolling Patients
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)
The MOMs Study is a national research study comparing two types of buprenorphine to see if one works better for mom and baby outcomes! Buprenorphine is a medication used to help treat opioid use disorder.
Below is a list of our active clinical trials.
Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly followed by Electroporation with Cellectra 2000 Alone or in Combination with Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
Phase III, Multicenter, Randomized Study of Atezolizumab versus Placebo Administered in Combination with Paclitaxel, Carboplatin, and Bevacizumab to Patients with Newly Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase I Study of Triapine in Combination with Chemradiation
Phase II Study of Copanlisib (BAY 80-6946) A Selective Inhibitor of P13KCA
Phase III Study of ADXS 11-001
Pissaro p53 Suppressor Activation in Serious Ovarian Cancer, A Phase Ib/II Study with Carboplatin
Randomized Open-Label Study Comparing the Combination of Yondelis and Doxil/Caelyx with Doxil/Caelyx Monotherapy for the Treatment of Advanced-Relapsed Ovarian Cancer